BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 14666730)

  • 1. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis.
    Greijer AE; van der Wall E
    J Clin Pathol; 2004 Oct; 57(10):1009-14. PubMed ID: 15452150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting.
    Delahoussaye YM; Hay MP; Pruijn FB; Denny WA; Brown JM
    Biochem Pharmacol; 2003 Jun; 65(11):1807-15. PubMed ID: 12781332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.
    Uto Y; Nagasawa H; Jin CZ; Nakayama S; Tanaka A; Kiyoi S; Nakashima H; Shimamura M; Inayama S; Fujiwara T; Takeuchi Y; Uehara Y; Kirk KL; Nakata E; Hori H
    Bioorg Med Chem; 2008 Jun; 16(11):6042-53. PubMed ID: 18474428
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Busk M; Eggertsen PP; Overgaard J; Horsman MR; Tørring T; Jacobsen KM; Poulsen TB
    Anticancer Res; 2023 Dec; 43(12):5319-5329. PubMed ID: 38030202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor hypoxia: a target for selective cancer therapy.
    Kizaka-Kondoh S; Inoue M; Harada H; Hiraoka M
    Cancer Sci; 2003 Dec; 94(12):1021-8. PubMed ID: 14662015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.
    Ribatti D
    Pharmaceuticals (Basel); 2010 Mar; 3(3):482-513. PubMed ID: 27713265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.
    Cheng G; Sa W; Cao C; Guo L; Hao H; Liu Z; Wang X; Yuan Z
    Front Pharmacol; 2016; 7():64. PubMed ID: 27047380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, preferentially hypoxic apoptosis and anti-angiogenic activity of 1,2,4-benzotrazin-3-amine 1,4-dioxide bearing alkyl linkers with 1,2,4-benzotrazin-3-amine 1-oxide derivatives.
    Huang WH
    Anticancer Agents Med Chem; 2014; 14(10):1428-46. PubMed ID: 25312508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.
    Weng Q; Zhang J; Cao J; Xia Q; Wang D; Hu Y; Sheng R; Wu H; Zhu D; Zhu H; He Q; Yang B
    Invest New Drugs; 2011 Dec; 29(6):1177-87. PubMed ID: 20524035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!
    Gaber T; Dziurla R; Tripmacher R; Burmester GR; Buttgereit F
    Ann Rheum Dis; 2005 Jul; 64(7):971-80. PubMed ID: 15800008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting HIF-1 for cancer therapy.
    Semenza GL
    Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.
    Nagasawa H; Mikamo N; Nakajima Y; Matsumoto H; Uto Y; Hori H
    Anticancer Res; 2003; 23(6a):4427-34. PubMed ID: 14666730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
    Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
    Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.